Stock & Company Details
Corvus Pharmaceuticals Inc $CRVS
Price:
N/A
N/A
84M
$859M
52 Week High:
N/A
10 Day Average Volume:
N/A
-16.38
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRVS technical indicators
Latest Corvus Pharmaceuticals Inc (CRVS) indicator readings as of 2026-10-09.
CRVS's 14-day RSI is 31.6, in neutral territory. At $10.52 it is trading 26.0% below its 200-day moving average of $14.22, and below its 50-day average of $13.23. Price sits near the lower Bollinger Band ($9.82 to $13.65). ADX reads 28.5, indicating a trending market.
Overview
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.
Finance Bot
Ask your questions
Start by typing a question below.
